Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial

Authors: Mette S. van Ramshorst, Anna van der Voort, Erik van Werkhoven, Ingrid A.M. Mandjes, Inge Kemper, Vincent O. Dezentjé, Irma M. Oving, Aafke H. Honkoop, Lidwine W. Tick, Agnès J. van de Wouw, Caroline M.P.W. Mandigers, Laurence J. van Warmerdam, Jelle Wesseling, Marie-Jeanne TFD Vrancken Peeters, Sabine C. Linn, Gabe S. Sonke - The Lancet 2018 cited by 445